Spotlight
Commentary
Cultural Corner
Psychiatric Practice
Series
News
Job Board
CME/CE
Partners
Editorial
Subscribe
Video
Increased Risk of Tardive Dyskinesia
Author(s):
How could drugs that block post-synaptic dopamine 2 receptors increase the risk for tardive dyskinesia over time?
John J. Miller, MD, talks about the increased risk of tardive dyskinesia on a synaptic level.
Dr Miller is medical director, Brain Health, Exeter, NH; editor in chief, Psychiatric TimesTM; staff psychiatrist, Seacoast Mental Health Center, Exeter, NH; consulting psychiatrist, Exeter Hospital, Exeter, NH; consulting psychiatrist, Insight Meditation Society, Barre, MA.
Related Videos
Related Content
